During the last session, Spero Therapeutics Inc (NASDAQ:SPRO)’s traded shares were 1.84 million, with the beta value of the company hitting 1.31. At the end of the trading day, the stock’s price was $2.94, reflecting an intraday gain of 1.38% or $0.04. The 52-week high for the SPRO share is $3.06, that puts it down -4.08 from that peak though still a striking 82.65% gain since the share price plummeted to a 52-week low of $0.51. The company’s market capitalization is $164.38M, and the average trade volume was 3.96 million shares over the past three months.
Spero Therapeutics Inc (SPRO) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 3.00. SPRO has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Spero Therapeutics Inc (NASDAQ:SPRO) trade information
Spero Therapeutics Inc (SPRO) registered a 1.38% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 1.38% in intraday trading to $2.94, hitting a weekly high. The stock’s 5-day price performance is 5.00%, and it has moved by 326.52% in 30 days. Based on these gigs, the overall price performance for the year is 116.18%.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.67%. While earnings are projected to return 9.45% in 2025, the next five years will return 7.97% per annum.
SPRO Dividends
Spero Therapeutics Inc is due to release its next quarterly earnings on 2025-May-13. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Spero Therapeutics Inc (NASDAQ:SPRO)’s Major holders
Spero Therapeutics Inc insiders own 24.39% of total outstanding shares while institutional holders control 23.25%, with the float percentage being 30.75%. ANSON FUNDS MANAGEMENT LP is the largest shareholder of the company, while 46.0 institutions own stock in it. As of 2024-06-30, the company held over 3.75 million shares (or 7.007% of all shares), a total value of $4.88 million in shares.
The next largest institutional holding, with 1.77 million shares, is of VANGUARD GROUP INC’s that is approximately 3.3079% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $2.3 million.
